Valuation: Labcorp Holdings Inc.

Market Cap 3.01TCr 2.7TCr 2.49TCr 2.26TCr 4.28TCr 2,82400Cr 4.4TCr 30TCr 12TCr 1,51300Cr 11TCr 11TCr 4,78200Cr P/E 2026 *
27.3x
P/E 2027 * 24.6x
Enterprise Value 3.53TCr 3.16TCr 2.92TCr 2.65TCr 5.01TCr 3,30800Cr 5.15TCr 35TCr 14TCr 1,77200Cr 13TCr 13TCr 5,60300Cr EV / Sales 2026 *
2.38x
EV / Sales 2027 * 2.22x
Free-Float
99.65%
Yield 2026 *
0.78%
Yield 2027 * 0.79%
1 day-0.26%
1 week+4.79%
Current month+2.63%
1 month+18.81%
3 months+15.43%
6 months+45.95%
Current year+47.83%
1 week 355.63
Extreme 355.63
373.76
1 month 310.11
Extreme 310.11
373.76
Current year 245
Extreme 245
373.76
1 year 245
Extreme 245
373.76
3 years 191.97
Extreme 191.97
373.76
5 years 191.97
Extreme 191.97
373.76
10 years 98.02
Extreme 98.02
373.76
Date Insider Type Main position Quantity % Market Cap. Importance
03/11/26 Sell

EVP and President, Diagnostics

-306 0.0004%
02/11/26 Tax

EVP and President, Diagnostics

-194 0.0002%
02/11/26 Tax

Chief Technology Officer

-118 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
-0.26%+4.79%+42.03%+81.11% 3.01TCr
+4.41%-2.63%+14.79%+31.52% 11TCr
-0.09%+8.98%+9.82%+116.66% 11TCr
-2.62%-19.72%+50.98%+567.48% 4.52TCr
-0.03%+9.55%+11.61%+113.54% 3.36TCr
-0.47%+4.61%+40.22%+94.58% 2.84TCr
+0.44%+8.84%+49.10%+439.64% 2.31TCr
-0.84%-0.23%-18.37%-18.37% 2TCr
-0.13%-0.64%-6.87%+30.80% 1.69TCr
+4.83%+3.79%+115.94% - 1.51TCr
Average +0.52%+1.52%+30.93%+161.88% 4TCr
Weighted average by Cap. +0.96%+1.11%+23.69%+145.95%

Financials

2026 *2027 *
Net sales 1.48TCr 1.33TCr 1.23TCr 1.11TCr 2.11TCr 1,39000Cr 2.17TCr 15TCr 5.85TCr 74TCr 5.56TCr 5.45TCr 2,35500Cr 1.56TCr 1.4TCr 1.29TCr 1.17TCr 2.22TCr 1,46500Cr 2.28TCr 15TCr 6.16TCr 78TCr 5.86TCr 5.74TCr 2,48100Cr
Net income 111.15Cr 100Cr 92Cr 83Cr 157.89Cr 10TCr 162.3Cr 1.1TCr 438.23Cr 5.58TCr 417.13Cr 408.28Cr 18TCr 121.77Cr 109.2Cr 100.64Cr 91Cr 172.98Cr 11TCr 177.81Cr 1.21TCr 480.12Cr 6.12TCr 456.99Cr 447.3Cr 19TCr
Net Debt 516.86Cr 463.52Cr 427.18Cr 387.95Cr 734.22Cr 48TCr 754.71Cr 5.11TCr 2.04TCr 26TCr 1.94TCr 1.9TCr 82TCr 459.42Cr 412.01Cr 379.71Cr 344.84Cr 652.63Cr 43TCr 670.85Cr 4.55TCr 1.81TCr 23TCr 1.72TCr 1.69TCr 73TCr
Projected Income Statement - Annual - Labcorp Holdings Inc.
Logo Labcorp Holdings Inc.
Labcorp Holdings Inc. provides comprehensive laboratory services that help doctors, hospitals, pharmaceutical companies, researchers and patients. The Company operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The BLS segment provides drug development and CDx development solutions from early-stage research to clinical development, along with support for crop protection and chemical testing, through its ED and Central Laboratory Services businesses. Its service also includes ambulatory outpatient laboratory services. The Company is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.
Employees
66,385
Date Price Change Volume
10/26/10 $370.88 -0.26% 5,10,426
09/26/09 $371.83 +1.43% 7,97,777
06/26/06 $366.57 +0.90% 6,10,114
05/26/05 $363.30 -1.22% 7,75,272
04/26/04 $367.79 +3.92% 8,09,673
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Labcorp Holdings Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
370.88USD
Average target price
390.06USD
Spread / Average Target
+5.17%